9/17/24 18:45 | 9/15/24 | ANAB | Anaptysbio, Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | D | | M.d | 0 | 0.00 | 0 | 1 | 64 | 3 | D | | | | | | | | | | | | | | |
6/18/24 20:15 | 6/15/24 | ANAB | Anaptysbio, Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | D | | M.d | 0 | 0.00 | 0 | 2 | New | 2 | D | | | | | | | | | | | | | | |
4/17/24 19:36 | 4/11/24 | BCEL | Atreca, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | P,CEO | P | 0 | 0.0100 | 0 | 0 | 0 | 78 | D | | | | | | | | | | | | | | |
4/3/24 21:37 | 9/1/23 | BCEL | Atreca, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | P,CEO | S | -9 | 0.3746 | 0 | -23 | -23 | 78 | D | | | | | | | | | | | | | | |
9/20/22 18:12 | 9/2/22 | BCEL | Atreca, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | P,CEO | S | -37 | 1.78 | 0 | -21 | -17 | 100 | D | | | | | | | | | | | | | | |
3/19/20 18:52 | 3/17/20 | BCEL | Atreca, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | P,CEO | P | 77 | 12.79 | 0 | 6 | New | 6 | D | | | | | | | | | | | | | | |
10/29/18 18:10 | 10/26/18 | ARRY | Array Biopharma Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | D | | M.d | 0 | 0.00 | 0 | 5 | 50 | 15 | D | | | | | | | | | | | | | | |
10/27/17 16:32 | 10/27/17 | ARRY | Array Biopharma Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | D | | M.d | 52 | 10.47 | 0 | 5 | 100 | 10 | D | | | | | | | | | | | | | | |
10/31/16 19:15 | 10/29/16 | ARRY | Array Biopharma Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | D | | M.d | 29 | 5.83 | 27 | 5 | New | 5 | D | 53 | 14 | 76 | 38 | 58 | -14 | -6 | -4 | 7 | 3 | 43 | 89 | 28 | |
2/17/16 19:50 | 2/12/16 | SGEN | Seattle Genetics Inc /wa | DE | Health | BioPrd | Biological Products, (No Diag | Orwin John A | WA | D | | P | 57 | 28.33 | 33 | 2 | 23 | 11 | D | -40 | -3 | -30 | -28 | -27 | -18 | -7 | 14 | -6 | -7 | 3 | 9 | 51 | 102 |
12/9/15 20:24 | 12/7/15 | RLYP | Relypsa Inc | | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | P,CEO | M.d | 74 | 7.40 | 33 | 10 | 23 | 54 | D | 37 | -1 | -21 | 18 | 90 | 50 | 16 | 25 | -2 | -5 | -27 | -56 | -36 | |
12/9/15 20:24 | 12/7/15 | RLYP | Relypsa Inc | | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | P,CEO | S.d | -424 | 28.28 | 33 | -15 | -22 | 54 | D | 37 | -1 | -21 | 18 | 90 | 50 | 16 | 25 | -2 | -5 | -27 | -56 | -36 | |
12/4/15 17:50 | 12/2/15 | RLYP | Relypsa Inc | | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | P,CEO | M.dm | 296 | 7.40 | 33 | 40 | 206 | 59 | D | 20 | -14 | -39 | 0 | 90 | 26 | 4 | -1 | -2 | -3 | -10 | -63 | -39 | |
12/4/15 17:50 | 12/2/15 | RLYP | Relypsa Inc | | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | P,CEO | S.dm | -1,000 | 25.00 | 33 | -40 | -40 | 59 | D | 20 | -14 | -39 | 0 | 90 | 26 | 4 | -1 | -2 | -3 | -10 | -63 | -39 | |
8/19/15 19:40 | 8/17/15 | RLYP | Relypsa Inc | | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | P,CEO | S | -124 | 24.84 | 19 | -5 | -11 | 43 | D | | -9 | -30 | -28 | -19 | -28 | -18 | 3 | -3 | -5 | -2 | -25 | -23 | 30 |
8/3/15 20:43 | 7/30/15 | RLYP | Relypsa Inc | | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | P,CEO | M.dm | 185 | 7.40 | 13 | 25 | New | 25 | D | | 46 | -6 | 9 | -3 | 2 | -5 | -4 | 1 | -10 | -31 | -52 | -43 | -4 |
8/3/15 20:43 | 7/30/15 | RLYP | Relypsa Inc | | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | P,CEO | S.dm | -1,007 | 33.56 | 13 | -30 | -55 | 25 | D | | 46 | -6 | 9 | -3 | 2 | -5 | -4 | 1 | -10 | -31 | -52 | -43 | -4 |
6/2/15 20:24 | 5/29/15 | RLYP | Relypsa Inc | | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | P,CEO | M.dm | 211 | 7.40 | 14 | 29 | 999% | 30 | D | | 51 | 44 | -9 | -1 | -2 | 3 | 0 | 2 | 3 | -5 | -29 | -31 | -44 |
6/2/15 20:24 | 5/29/15 | RLYP | Relypsa Inc | | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | P,CEO | S.dm | -1,222 | 36.42 | 14 | -34 | -53 | 30 | D | | 51 | 44 | -9 | -1 | -2 | 3 | 0 | 2 | 3 | -5 | -29 | -31 | -44 |
11/20/13 19:10 | 11/20/13 | RLYP | Relypsa Inc | | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | P,CEO | P | 165 | 11.00 | 12 | 15 | New | 15 | D | | | | | | | | | 5 | 29 | 117 | 233 | 112 | 80 |
2/5/13 20:36 | 2/1/13 | AFFY | Affymax Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | CEO | M.d | 42 | 6.53 | 0 | 6 | 6 | 108 | D | | | | | | | | | | | | | | |
2/5/13 20:36 | 2/1/13 | AFFY | Affymax Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | CEO | S.d | -120 | 18.81 | 0 | -6 | -6 | 108 | D | | | | | | | | | | | | | | |
12/4/12 19:16 | 12/3/12 | AFFY | Affymax Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | CEO | M.d | 105 | 6.68 | 0 | 16 | 21 | 92 | D | | | | | | | | | | | | | | |
12/4/12 19:16 | 12/3/12 | AFFY | Affymax Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | CEO | S.d | -383 | 24.22 | 0 | -16 | -15 | 92 | D | | | | | | | | | | | | | | |
10/9/12 19:42 | 10/5/12 | AFFY | Affymax Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | CEO | M.d | 287 | 6.90 | 0 | 42 | 83 | 92 | D | | | | | | | | | | | | | | |
10/9/12 19:42 | 10/5/12 | AFFY | Affymax Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | CEO | S.d | -937 | 22.50 | 0 | -42 | -31 | 92 | D | | | | | | | | | | | | | | |
10/3/12 10:32 | 10/1/12 | AFFY | Affymax Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | CEO | M.d | 77 | 6.60 | 0 | 12 | 14 | 92 | D | | | | | | | | | | | | | | |
10/3/12 10:32 | 10/1/12 | AFFY | Affymax Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | CEO | S.d | -245 | 21.04 | 0 | -12 | -11 | 92 | D | | | | | | | | | | | | | | |
9/17/12 21:12 | 9/13/12 | AFFY | Affymax Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | CEO | M.d | 326 | 6.65 | 0 | 49 | 114 | 92 | D | | | | | | | | | | | | | | |
9/17/12 21:12 | 9/13/12 | AFFY | Affymax Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | CEO | S.d | -980 | 20.00 | 0 | -49 | -35 | 92 | D | | | | | | | | | | | | | | |
8/22/12 19:43 | 8/20/12 | AFFY | Affymax Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | CEO | M.d | 326 | 6.65 | 0 | 49 | 114 | 92 | D | | | | | | | | | | | | | | |
8/22/12 19:43 | 8/20/12 | AFFY | Affymax Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | CEO | S.d | -857 | 17.50 | 0 | -49 | -35 | 92 | D | | | | | | | | | | | | | | |
8/3/12 16:54 | 8/1/12 | AFFY | Affymax Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | CEO | M.d | 6 | 5.83 | 0 | 1 | 1 | 92 | D | | | | | | | | | | | | | | |
8/3/12 16:54 | 8/1/12 | AFFY | Affymax Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | CEO | S.d | -18 | 16.31 | 0 | -1 | -1 | 92 | D | | | | | | | | | | | | | | |
7/17/12 20:49 | 7/13/12 | AFFY | Affymax Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | CEO | M.d | 13 | 5.83 | 0 | 2 | 2 | 92 | D | | | | | | | | | | | | | | |
7/17/12 20:49 | 7/13/12 | AFFY | Affymax Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | CEO | S.d | -281 | 15.00 | 0 | -19 | -17 | 92 | D | | | | | | | | | | | | | | |
5/1/12 18:31 | 4/27/12 | AFFY | Affymax Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | CEO | S | -401 | 13.35 | 0 | -30 | -22 | 109 | D | | | | | | | | | | | | | | |
4/5/12 17:10 | 4/3/12 | AFFY | Affymax Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | CEO | S | -197 | 11.93 | 0 | -17 | -11 | 139 | D | | | | | | | | | | | | | | |
3/29/12 16:12 | 3/27/12 | AFFY | Affymax Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | CEO | M.d | 48 | 5.83 | 0 | 8 | 6 | 155 | D | | | | | | | | | | | | | | |
3/29/12 16:12 | 3/27/12 | AFFY | Affymax Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | CEO | S.d | -129 | 15.70 | 0 | -8 | -5 | 155 | D | | | | | | | | | | | | | | |
2/6/12 20:41 | 2/2/12 | AFFY | Affymax Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | CEO | S | -180 | 10.00 | 10 | -18 | -10 | 155 | D | -48 | 56 | 83 | 101 | 58 | 46 | 45 | 30 | 1 | -1 | 0 | | | |
8/18/11 20:00 | 8/18/11 | AFFY | Affymax Inc | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | CEO | S | -55 | 4.55 | 4 | -12 | -8 | 148 | D | -76 | -30 | -26 | -28 | -35 | -31 | 1 | 5 | 2 | 3 | 5 | 6 | 138 | |